{"id":"https://openalex.org/W1991497833","doi":"https://doi.org/10.1212/wnl.38.11.1667","title":"(S)\u2010Emopamil, a novel calcium channel blocker and serotonin S 2 antagonist, markedly reduces infarct size following middle cerebral artery occlusion in the rat","display_name":"(S)\u2010Emopamil, a novel calcium channel blocker and serotonin S 2 antagonist, markedly reduces infarct size following middle cerebral artery occlusion in the rat","alternate_titles":[],"publication_year":1988,"publication_date":"1988-11-01","ids":{"openalex":"https://openalex.org/W1991497833","doi":"https://doi.org/10.1212/wnl.38.11.1667","mag":"1991497833","pmid":"https://pubmed.ncbi.nlm.nih.gov/3185899"},"language":"en","primary_location":{"id":"doi:10.1212/wnl.38.11.1667","doi":"https://doi.org/10.1212/wnl.38.11.1667","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.38.11.1667","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1991497833"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5044132578","display_name":"Hitoshi Nakayama","orcid":"https://orcid.org/0000-0002-6077-6172","observed_orcids":["https://orcid.org/0000-0002-6077-6172"]},"institutions":[{"id":"https://openalex.org/I145608581","display_name":"University of Miami","ror":"https://ror.org/02dgjyy92","country_code":"US","type":"education","lineage":["https://openalex.org/I145608581"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hitoshi Nakayama","raw_affiliation_strings":["Cerebral Vascular Disease Research Center, Department of Neurology, University of Miami School of Medicine, Miami, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cerebral Vascular Disease Research Center, Department of Neurology, University of Miami School of Medicine, Miami, FL","institution_ids":["https://openalex.org/I145608581"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109242926","display_name":"Myron D. Ginsberg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145608581","display_name":"University of Miami","ror":"https://ror.org/02dgjyy92","country_code":"US","type":"education","lineage":["https://openalex.org/I145608581"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Myron D. Ginsberg","raw_affiliation_strings":["Cerebral Vascular Disease Research Center, Department of Neurology, University of Miami School of Medicine, Miami, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cerebral Vascular Disease Research Center, Department of Neurology, University of Miami School of Medicine, Miami, FL","institution_ids":["https://openalex.org/I145608581"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5011373172","display_name":"W. Dalton Dietrich","orcid":"https://orcid.org/0000-0002-8732-4942","observed_orcids":["https://orcid.org/0000-0002-8732-4942"]},"institutions":[{"id":"https://openalex.org/I145608581","display_name":"University of Miami","ror":"https://ror.org/02dgjyy92","country_code":"US","type":"education","lineage":["https://openalex.org/I145608581"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"W. Dalton Dietrich","raw_affiliation_strings":["Cerebral Vascular Disease Research Center, Department of Neurology, University of Miami School of Medicine, Miami, FL","Neurological Surgery"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cerebral Vascular Disease Research Center, Department of Neurology, University of Miami School of Medicine, Miami, FL","institution_ids":["https://openalex.org/I145608581"]},{"raw_affiliation_string":"Neurological Surgery","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I145608581"],"apc_list":null,"apc_paid":null,"fwci":7.6689,"has_fulltext":false,"cited_by_count":139,"citation_normalized_percentile":{"value":0.97774958,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"38","issue":"11","first_page":"1667","last_page":"1667"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10227","display_name":"Acute Ischemic Stroke Management","score":0.9717000126838684,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10227","display_name":"Acute Ischemic Stroke Management","score":0.9717000126838684,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13796","display_name":"Neuroprotection in Cerebral Ischemia","score":0.025299999862909317,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10706","display_name":"Traumatic Brain Injury and Neurovascular Disturbances","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/calcium-channel-blockers","display_name":"calcium channel blockers","score":0.7919999957084656},{"id":"https://openalex.org/keywords/middle-cerebral-artery-occlusion","display_name":"middle cerebral artery occlusion","score":0.9049999713897705},{"id":"https://openalex.org/keywords/cerebral-infarction","display_name":"cerebral infarction","score":0.7210000157356262},{"id":"https://openalex.org/keywords/infarct-size","display_name":"infarct size","score":0.7710000276565552},{"id":"https://openalex.org/keywords/ischemic-stroke","display_name":"ischemic stroke","score":0.6389999985694885},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.7070000171661377},{"id":"https://openalex.org/keywords/blood-brain-barrier-permeability","display_name":"blood-brain barrier permeability","score":0.7509999871253967},{"id":"https://openalex.org/keywords/striatal-infarction","display_name":"striatal infarction","score":0.6539999842643738},{"id":"https://openalex.org/keywords/treatment-delay","display_name":"treatment delay","score":0.5260000228881836}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7168473601341248},{"id":"https://openalex.org/C2777222312","wikidata":"https://www.wikidata.org/wiki/Q726562","display_name":"Neocortex","level":2,"score":0.654904842376709},{"id":"https://openalex.org/C2775841333","wikidata":"https://www.wikidata.org/wiki/Q498179","display_name":"Middle cerebral artery","level":3,"score":0.6536085605621338},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.6345426440238953},{"id":"https://openalex.org/C2777397205","wikidata":"https://www.wikidata.org/wiki/Q275792","display_name":"Saline","level":2,"score":0.6261250972747803},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.5954371690750122},{"id":"https://openalex.org/C2776268601","wikidata":"https://www.wikidata.org/wiki/Q968808","display_name":"Occlusion","level":2,"score":0.5897865295410156},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.5746488571166992},{"id":"https://openalex.org/C2780356492","wikidata":"https://www.wikidata.org/wiki/Q421700","display_name":"Calcium channel blocker","level":3,"score":0.5481508374214172},{"id":"https://openalex.org/C2777798775","wikidata":"https://www.wikidata.org/wiki/Q207550","display_name":"Infarction","level":3,"score":0.483646035194397},{"id":"https://openalex.org/C519063684","wikidata":"https://www.wikidata.org/wiki/Q706","display_name":"Calcium","level":2,"score":0.41312891244888306},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3774200975894928},{"id":"https://openalex.org/C541997718","wikidata":"https://www.wikidata.org/wiki/Q188151","display_name":"Ischemia","level":2,"score":0.3620098829269409},{"id":"https://openalex.org/C500558357","wikidata":"https://www.wikidata.org/wiki/Q12152","display_name":"Myocardial infarction","level":2,"score":0.09255006909370422},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.07585182785987854},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002121","descriptor_name":"Calcium Channel Blockers","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002536","descriptor_name":"Cerebral Arteries","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002544","descriptor_name":"Cerebral Infarction","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002544","descriptor_name":"Cerebral Infarction","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011919","descriptor_name":"Rats, Inbred Strains","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012702","descriptor_name":"Serotonin Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014700","descriptor_name":"Verapamil","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D014700","descriptor_name":"Verapamil","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1212/wnl.38.11.1667","doi":"https://doi.org/10.1212/wnl.38.11.1667","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.38.11.1667","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"},{"id":"pmid:3185899","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3185899","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[{"id":"https://openalex.org/G130134820","display_name":null,"funder_award_id":"NS-05820","funder_id":"https://openalex.org/F4320337359","funder_display_name":"National Institute of Neurological Disorders and Stroke"},{"id":"https://openalex.org/G8487609222","display_name":"VULNERABILITY TO BRAIN ISCHEMIA:ROLE OF NEURAL ACTIVITY","funder_award_id":"R01NS022603","funder_id":"https://openalex.org/F4320337359","funder_display_name":"National Institute of Neurological Disorders and Stroke"}],"funders":[{"id":"https://openalex.org/F4320337359","display_name":"National Institute of Neurological Disorders and Stroke","ror":"https://ror.org/01s5ya894"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2023134767","https://openalex.org/W2043336941","https://openalex.org/W2438727183","https://openalex.org/W2079600778","https://openalex.org/W2474957819","https://openalex.org/W1969605298","https://openalex.org/W2074555102","https://openalex.org/W2062939383","https://openalex.org/W1966169498","https://openalex.org/W2423061645"],"abstract_inverted_index":{"(S)-Emopamil":[0],"is":[1,179],"a":[2],"novel":[3],"calcium":[4],"channel":[5],"blocker":[6],"of":[7,28,34,138,162,170],"the":[8,26,31,149,166],"phenylalkylamine":[9],"class,":[10],"with":[11,116],"superior":[12],"blood-brain":[13],"permeability":[14],"and":[15,68,80,88,97,113,121,131],"potent":[16],"serotonin":[17],"S2":[18],"antagonist":[19],"activity.":[20],"In":[21,45,146],"this":[22,163],"study,":[23],"we":[24],"investigated":[25],"effects":[27],"(S)-emopamil":[29,50,158,171],"on":[30],"histopathologic":[32],"consequences":[33],"permanent":[35],"middle":[36],"cerebral":[37],"artery":[38],"(MCA)":[39],"occlusion":[40],"in":[41,78,110,114,172],"anesthetized":[42],"Sprague-Dawley":[43],"rats.":[44],"three":[46],"treatment":[47,178],"protocols,":[48],"intraperitoneal":[49],"therapy":[51],"was":[52,140,154],"begun":[53],"either":[54],"30":[55],"minutes":[56],"prior":[57],"to,":[58],"immediately":[59],"after,":[60],"or":[61],"1":[62,122,182],"hour":[63,183],"after":[64],"MCA":[65,185],"occlusion.":[66,186],"Nontreated":[67],"saline-treated":[69,81],"control":[70,82,144],"groups":[71],"were":[72,84,124],"also":[73],"studied.":[74],"Cortical":[75],"infarct":[76,107,152],"volumes":[77],"nontreated":[79],"rats":[83,115],"85":[85],"+/-":[86,90,94,126,129,133],"22":[87],"66":[89],"19":[91],"mm3":[92],"(mean":[93],"SD),":[95],"respectively,":[96],"did":[98],"not":[99,155],"differ":[100],"statistically":[101],"from":[102],"one":[103],"another.":[104],"Corresponding":[105],"cortical":[106,174],"volume":[108,153],"values":[109],"(S)-emopamil-pretreated":[111],"rats,":[112],"post-treatment":[117],"at":[118],"0":[119],"hours":[120],"hour,":[123],"33":[125],"23,":[127],"29":[128],"14,":[130],"27":[132],"16":[134],"mm3,":[135],"respectively;":[136],"each":[137],"these":[139],"significantly":[141],"smaller":[142],"than":[143],"values.":[145],"contrast":[147],"to":[148],"neocortex,":[150],"striatal":[151],"altered":[156],"by":[157],"treatment.":[159],"The":[160],"results":[161],"study":[164],"demonstrate":[165],"marked":[167],"therapeutic":[168],"efficacy":[169],"focal":[173],"infarction,":[175],"even":[176],"when":[177],"delayed":[180],"for":[181],"following":[184]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1991497833","counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
